Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Industry News

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

December 06, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

News Industry News

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

July 27, 2021

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Industry News

preCARDIA Enrolls First Patient in Early Feasibility Study

August 15, 2019

News Industry News

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

July 22, 2019

News Industry News

VisCardia Announces Completion of Enrollment and Three Month Follow-Up Visits for Its VisONE® Heart Failure Pilot Study

April 22, 2019

News Industry News

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

August 27, 2018

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Industry News

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

September 19, 2017

News Industry News

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

July 20, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

May 11, 2017

News Industry News

LivaNova Launches Next Generation ICD and CRT-D Devices in the United States

September 23, 2016

News Industry News

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

June 27, 2016

News Industry News

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

June 06, 2016

News Industry News

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

May 04, 2016

News Industry News

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

May 02, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

Advertisement

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

preCARDIA Enrolls First Patient in Early Feasibility Study

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

VisCardia Announces Completion of Enrollment and Three Month Follow-Up Visits for Its VisONE® Heart Failure Pilot Study

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

LivaNova Launches Next Generation ICD and CRT-D Devices in the United States

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content